BioRestorative Therapies, Inc. BRTX
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.06M | -14.24M | -12.67M | -10.72M | -12.10M |
| Total Depreciation and Amortization | 210.50K | 209.90K | 207.50K | 203.20K | 198.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.54M | 1.93M | 1.24M | 630.90K | 2.73M |
| Change in Net Operating Assets | 570.90K | 1.31M | 502.70K | 369.50K | 473.20K |
| Cash from Operations | -11.82M | -10.79M | -10.72M | -9.52M | -8.69M |
| Capital Expenditure | -79.70K | -116.10K | -48.80K | -107.30K | -142.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.58M | 9.01M | 8.08M | 7.08M | 7.95M |
| Cash from Investing | 7.50M | 8.90M | 8.03M | 6.97M | 7.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.01M | 3.14M | 2.65M | 2.65M | 1.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -808.20K | -282.60K | -843.80K | -794.50K | -768.10K |
| Cash from Financing | 6.20M | 2.85M | 1.81M | 1.85M | 953.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.88M | 963.30K | -887.00K | -697.00K | 71.70K |